Conmed (CNMD) Shares Outstanding (2010 - 2026)
Conmed (CNMD) posted Shares Outstanding (Entity) of $31.3 million for Q1 2026, little changed on a QoQ basis from $31.3 million in Q4 2025, and little changed year-over-year from $31.3 million in Q1 2025.
Conmed (CNMD) Shares Outstanding (2010 - 2026) Analysis & Trends
Conmed's Shares Outstanding (Entity) history runs 17 years deep, the most recent figure standing at $31.3 million for Q1 2026.
- Quarterly Shares Outstanding (Entity) changed 0.0% year-over-year to $31.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.3 million (changed 0.0% YoY) and the FY2025 annual result came in at $31.3 million, changed 0.0% from the prior year.
- Shares Outstanding (Entity) was $31.3 million for Q1 2026 at Conmed, roughly flat from $31.3 million in the prior quarter.
- Across five years, Shares Outstanding (Entity) topped out at $31.3 million in Q1 2022 and bottomed at $31.3 million in Q1 2022.
- A 5-year average of $31.3 million and a median of $31.3 million in 2022 frame the typical range for Shares Outstanding (Entity).
- Peak annual rise in Shares Outstanding (Entity) reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
- Conmed's Shares Outstanding (Entity) stood at $31.3 million in 2022, then changed by 0.0% to $31.3 million in 2023, then changed by 0.0% to $31.3 million in 2024, then changed by 0.0% to $31.3 million in 2025, then changed by 0.0% to $31.3 million in 2026.
- Business Quant data shows CNMD's Shares Outstanding (Entity) at $31.3 million in Q1 2026, $31.3 million in Q4 2025, and $31.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.74 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 382.90 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 1.28 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 1.48 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 579.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 385.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 951.57 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 456.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 867.00 Mn |
| 10 | Conmed | 1.29 Bn | 1.26 Bn | 183.45 Mn | 30.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 30.59 Mn |
| Dec 31, 2025 | 31.04 Mn |
| Sep 30, 2025 | 30.96 Mn |
| Jun 30, 2025 | 30.95 Mn |
| Mar 31, 2025 | 30.97 Mn |
| Dec 31, 2024 | 30.85 Mn |
| Sep 30, 2024 | 30.86 Mn |
| Jun 30, 2024 | 30.81 Mn |
| Mar 31, 2024 | 30.78 Mn |
| Dec 31, 2023 | 30.67 Mn |
| Sep 30, 2023 | 30.74 Mn |
| Jun 30, 2023 | 30.66 Mn |
| Mar 31, 2023 | 30.51 Mn |
| Dec 31, 2022 | 30.04 Mn |
| Sep 30, 2022 | 30.47 Mn |
| Jun 30, 2022 | 29.78 Mn |
| Mar 31, 2022 | 29.43 Mn |
| Dec 31, 2021 | 29.16 Mn |
| Sep 30, 2021 | 29.18 Mn |
| Jun 30, 2021 | 29.13 Mn |